Try our Advanced Search for more refined results
9,220,631
Syringe
- July 21, 2022 PTAB Mulls Validity Of Novartis Syringe IP In Regeneron Fight
- February 01, 2022 Novartis Ducks Regeneron's Antitrust Countersuit To IP Fight
- October 27, 2021 Regeneron Gets PTAB To Review Syringe Patent On 2nd Go
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
View all the results
Already a subscriber? Click here to login